Xuefang Pan Selected Research

Xuefang Pan Research Topics

Disease

4	Atherosclerosis 02/2023 - 09/2011
3	Mucopolysaccharidosis III (Sanfilippo Syndrome) 04/2024 - 01/2022
3	Mucopolysaccharidoses 04/2024 - 01/2022
3	Mucolipidoses (Sialidosis) 10/2023 - 07/2013
2	Neuraminidase 1 deficiency 04/2024 - 10/2023
2	Muscular Diseases (Myopathy) 01/2023 - 12/2018
2	Memory Disorders (Memory Loss) 01/2022 - 01/2017
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 04/2024
1	Fibrosis (Cirrhosis) 10/2023
1	Urinary Retention 10/2023
1	Inflammation (Inflammations) 02/2023
1	Alzheimer Disease (Alzheimer's Disease) 02/2023
1	Cognitive Dysfunction 02/2023
1	Disease Progression 01/2023
1	Cardiac Edema 01/2023
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Neoplasm Metastasis (Metastasis) 12/2018
1	Infections 12/2018
1	Sialic Acid Storage Disease (Salla Disease) 12/2018
1	Insulin Resistance 01/2018
1	Hyperglycemia 01/2018
1	Glucose Intolerance 01/2018
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Tay-Sachs Disease 01/2017
1	Gliosis 01/2017
1	Gangliosidoses (Gangliosidosis) 01/2017
1	Hereditary Corneal Dystrophies 01/2017
1	Neuroinflammatory Diseases 01/2017
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2014
1	of Schnyder Crystalline Corneal Dystrophy 01/2014
1	Carcinogenesis 10/2005

Drug/Important Bio-Agent (IBA)

5	Neuraminidase (Sialidase)IBA 04/2024 - 01/2017
4	Apolipoproteins E (ApoE)IBA 02/2023 - 09/2011
3	Cathepsin AIBA 04/2024 - 01/2017
3	EnzymesIBA 04/2024 - 01/2017
3	Glycoproteins (Glycoprotein)IBA 04/2024 - 12/2018
3	CholesterolIBA 02/2023 - 01/2014
3	ApolipoproteinsIBA 01/2021 - 09/2011
2	Polysaccharides (Glycans)IBA 04/2024 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2018
2	LipidsIBA 02/2023 - 01/2021
2	N-acetylneuraminate lyaseIBA 01/2023 - 12/2018
2	GlycolipidsIBA 01/2021 - 12/2018
2	LDL Receptors (LDL Receptor)IBA 01/2021 - 09/2011
2	Insulin (Novolin)FDA Link 01/2018 - 07/2013
1	GlycosaminoglycansIBA 04/2024
1	polysialic acidIBA 04/2024
1	GalactosidasesIBA 04/2024
1	SulfatasesIBA 04/2024
1	AlbuminsIBA 10/2023
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 10/2023
1	CytokinesIBA 02/2023
1	caffeic acidIBA 02/2023
1	Interleukin-6 (Interleukin 6)IBA 02/2023
1	Messenger RNA (mRNA)IBA 02/2023
1	N-acetylmannosamineIBA 01/2023
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2022
1	Glucosamine (Dona)IBA 01/2022
1	AcetyltransferasesIBA 01/2022
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2022
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2021
1	Benzoates (Benzoate)IBA 01/2021
1	Asialoglycoprotein ReceptorIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	Lysergic Acid Diethylamide (LSD)IBA 01/2021
1	ethyl gallateIBA 01/2021
1	Apolipoprotein B-100 (Apo B 100)IBA 01/2021
1	AcetylglucosamineIBA 12/2018
1	Sialic AcidsIBA 12/2018
1	Insulin ReceptorIBA 01/2018
1	Ambroxol (Mucosolvan)IBA 01/2018
1	PalmitatesIBA 01/2018
1	LipofuscinIBA 01/2017
1	Serine (L-Serine)FDA Link 01/2017
1	serine carboxypeptidaseIBA 01/2017
1	GangliosidesIBA 01/2017
1	G(M3) GangliosideIBA 01/2017
1	G(M1) GangliosideIBA 01/2017
1	CarboxypeptidasesIBA 01/2017
1	SialoglycoproteinsIBA 01/2015
1	Prion ProteinsIBA 01/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014
1	Protein Kinases (Protein Kinase)IBA 07/2013
1	Carrier Proteins (Binding Protein)IBA 09/2011
1	Adenosine Triphosphate (ATP)IBA 10/2005

Therapy/Procedure

1	Oral Administration 01/2023
1	Therapeutics 01/2023
1	Transplantation 09/2011